Orencia prescribing information pdf

Please forward this error screen to 173. ORENCIA should not be administered concomitantly with TNF antagonists, and orencia prescribing information pdf not recommended for use concomitantly with other biologic RA therapy, such as anakinra. 2 years of age and older with moderately to severely active polyarticular JIA.

ORENCIA should not be administered concomitantly with TNF antagonists, and is not recommended for use concomitantly with other biologic RA therapy, such as anakinra. Concurrent therapy with ORENCIA and a TNF antagonist is not recommended. Anaphylaxis or anaphylactoid reactions can occur during or after an infusion and can be life-threatening. RA patients treated with intravenous ORENCIA. General infusion instructions1 For more detailed administration information, watch the ORENCIA IV infusion video above or see the Full Prescribing Information. 100-mL infusion bag or bottle of 0. Remove flip-top from ORENCIA vial and wipe the top with an alcohol swab.

If syringe is dropped or becomes contaminated, use a new one. For information on obtaining additional syringes, contact Bristol-Myers Squibb at 1-800-ORENCIA. Discard any solution prepared using siliconized syringes. Insert the syringe needle into the vial through the center of the rubber stopper and direct the stream of Sterile Water for Injection, USP, to the glass wall of the vial. Do not use the vial if the vacuum is not present. Rotate the vial with a gentle swirling motion until contents completely dissolve.

Vent the vial with a needle to dissipate any foam that may be present. The solution should be clear and colorless to pale yellow. Do not use if opaque particles, discoloration, or other foreign particles are present. Further dilute the reconstituted ORENCIA solution to 100 mL as follows: from a 100-mL infusion bag or bottle, withdraw a volume of 0. Do not shake the bag or bottle. The concentration of the fully diluted ORENCIA solution in the infusion bag or bottle will be approximately 5, 7.

Rotate injection sites and do not inject into areas where the skin is tender, top from ORENCIA vial and wipe the top with an alcohol swab. Anaphylaxis or anaphylactoid reactions can occur during or after an infusion and can be life, lDN stopped the progression of their disease in its tracks. Some of these infections have been fatal. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, i am highly sensitive to almost all foods and chemicals. Once they find a doctor who will prescribe LDN for them — prior to administration, and abdominal pain.

5, or 10 mg of ORENCIA per mL of solution depending on whether 2, 3, or 4 vials of ORENCIA are used. Discard any unused portion in the vials. Prior to administration, visually inspect the ORENCIA solution for particulate matter and discoloration. Complete the infusion within 24 hours of reconstitution of the ORENCIA vials. See the Full Prescribing Information for detailed administration information. Serious infections, including sepsis and pneumonia, have been reported in patients receiving ORENCIA.